If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.



One-Pot Sulfonylated Pyridines

Process chemists report a concise synthesis of valuable building blocks used in medicinal and agricultural chemistry

by Stephen K. Ritter
December 13, 2010 | A version of this story appeared in Volume 88, Issue 50

Process chemists at Merck & Co. report concise synthesis of functionalized sulfonylated pyridines—valuable building blocks in both medicinal and agricultural chemistry (Org. Lett., DOI: 10.1021/ol102629c). Besides their utility as intermediates in organic synthesis, these compounds have been shown to be anti-­inflammatory, antihyperglycemic, and ­immunosuppressive agents, as well as inhibitors of HIV-1 reverse transcriptase. Sulfonylated pyridines are typically synthesized by displacing a halogen from a halopyridine with a thiol in basic solution, followed by oxidation. But this two-step approach is problematic because of the odiferous thiols and the large amount of hazardous waste generated. Merck’s Kevin M. Maloney, Jeffrey T. Kuethe, and Kathleen Linn developed a more streamlined nucleophilic aromatic substitution reaction in which a sulfinic acid salt converts chloropyridines directly to sulfonylated pyridines. The one-pot reactions, accelerated by the addition of tetrabutylammonium chloride (TBACl) as a phase-transfer catalyst, provided high yields and required no chromatographic purification. The team prepared a variety of sulfonylated pyridines starting from chloropyridines, substituted chloropyridines, and dichloropyridines. “The method is safe, scalable, and significantly greener than current alternatives,” the researchers write.


This article has been sent to the following recipient:

Chemistry matters. Join us to get the news you need.